Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f44a70d66a63d40b6e7b06facc79ec8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81764304ab2ca272921b17fe72b20ba1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_761431b64a56c1b76e009fca423a7de4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73578b5c18cf06acb4a1cc629ccb7abc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6472a737f85c5956f430d21ccf91bba0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2009-05-19^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-01-10^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7979ee4165305082d3b165211fc9c4ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320cb2a8be2efa546e1712e01b409bd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c5c1843f3b21826cec8e49e1b73071a |
publicationDate |
2017-01-10^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9540695-B2 |
titleOfInvention |
Compositions and methods for prognosis of ovarian cancer |
abstract |
Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom. |
priorityDate |
2008-06-17^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |